Drug Repurposing News and Research

RSS

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).

28 Feb 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Drug repurposing study finds lonafarnib effective against RSV

A study in Nature Communications identifies lonafarnib from the ReFRAME drug-repurposing library as a potent inhibitor of the RSV fusion protein, showing promise in reducing RSV infection in vitro and in vivo.

11 Feb 2024

Study identifies more than 200 new genes linked to depression

More than 200 genes linked to depression have been newly identified in a worldwide study led by UCL researchers.

10 Jan 2024

Deep learning unlocks new antibiotic classes, revolutionizing the fight against resistance

A Nature journal study employs deep learning to analyze chemical sub-structures, leading to the discovery of new structural classes of antibiotics, showcasing the potential of AI in accelerating antibiotic development.

20 Dec 2023

New AI framework can rapidly identify new use cases for existing therapeutics

Scientists at Klick Applied Sciences have created an artificial intelligence framework that can rapidly identify new use cases for existing therapeutics, according to findings presented Friday at the NeurIPS conference that could greatly improve the drug repurposing process and transform the pharmaceutical industry.

15 Dec 2023

COST's Network of Actions against COVID-19

Throughout history, infectious diseases have been a constant presence, and this is still the case today, with frequent outbreaks.

7 Dec 2023

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

Kidney stones affect nearly 10% of the global population. For more than three decades, thiazide diuretics, a common medication used for high blood pressure, have been the standard of care for kidney stone prevention because they reduce the excretion of urinary calcium.

30 Nov 2023

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Talk to focus on the spinout journey from drug repurposing to clinical trials for diagnosing and treating Alzheimer’s Disease.

28 Nov 2023

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet published in the Journal of Internal Medicine.

22 Nov 2023

New research explores the unique effects of ADHD medications on Drosophila brain cells

The effect of two drugs used for the treatment of attention-deficit/hyperactivity disorder.

15 Nov 2023

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidXploreTM.

13 Nov 2023

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the unique aspects of Phenaros' drug discovery platform, and the synergy between academia and industry.

From ELRIG (UK) Ltd. 1 Nov 2023

MuTaLig: A multi-target paradigm for innovative drug discoveries

Everyone at some point in their life may need to take medication to treat an illness or disease. By finding new and better ways to create drugs, the COST Action Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) helped improve the effectiveness and safety of the medications, which can ultimately benefit people's health and well-being.

19 Oct 2023

Drug Repurposing News and Research

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Drug repurposing study finds lonafarnib effective against RSV

Study identifies more than 200 new genes linked to depression

Deep learning unlocks new antibiotic classes, revolutionizing the fight against resistance

New AI framework can rapidly identify new use cases for existing therapeutics

COST's Network of Actions against COVID-19

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

New research explores the unique effects of ADHD medications on Drosophila brain cells

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

MuTaLig: A multi-target paradigm for innovative drug discoveries

Extending FDA-approved cancer drug indications requires high patient numbers, study finds

Proxalutamide shows promise as potential COVID-19 treatment

Study explores the use of existing medicines to revolutionize cancer treatment

Understanding the molecular mechanisms responsible for antimony drug resistance in Leishmania parasites

Repurposed drug effective at inhibiting a protein kinase linked to cardiac arrhythmias

Metformin shows promising antiviral activity against SARS-CoV-2

Drug Discovery - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News